CSIMarket Company Name, Ticker, Competitors, else..
 
Processa Pharmaceuticals Inc   (NASDAQ: PCSA)
 
Price: $2.0600 $0.01 0.488%
Day's High: $2.0829999446868896 Week Perf: 0.49 %
Day's Low: $ 2.01 30 Day Perf: -10.43 %
Volume (M): 12,300 52 Wk High: $ 14.25
Volume (M$): $ 0 52 Wk Avg: $3.84
Open: $2.02 52 Wk Low: $1.67



 Market Capitalization (Millions $) 6
 Shares Outstanding (Millions) 3
 Employees 12
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -13
 Cash Flow (TTM) (Millions $) -5
 Capital Exp. (TTM) (Millions $) 0

Business Description


Processa Pharmaceuticals Inc. is a biopharmaceutical company that focuses on the development and commercialization of drug therapies for patients with unmet medical needs. The company primarily focuses on developing drugs for the treatment of rare diseases and conditions. Processa Pharmaceuticals aims to improve patient outcomes and quality of life by bringing innovative therapies to market. They conduct clinical trials, collaborate with research institutions, and seek regulatory approvals to bring their drugs to market. Their ultimate goal is to become a leading provider of effective and accessible treatments for rare diseases.


   Company Address: 601 21st Street Vero Beach 32960 FL
   Company Phone Number: 453-2899   Stock Exchange / Ticker: NASDAQ PCSA


Customers Net Income fell by PCSA's Customers Net Profit Margin fell to

-17.21 %
15.69 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
JAGX   -26.3%    
VKTX        8.43% 
VRTX        0.82% 
DE        10.03% 
DOV   -2.92%    
EMR   -1.52%    
• View Complete Report
   



Stocks on the Move

Processa Pharmaceuticals Inc Faces Recent Stock Decline Amidst Pharmaceutical Industry Challenges

Published Tue, Jul 9 2024 9:58 AM UTC

Processa Pharmaceuticals Inc Shares Trail Market Performance Amidst Recent DeclineProcessa Pharmaceuticals Inc has experienced a decline in share performance over the past week, trailing the overall market trends. However, it is worth noting that over the past 12 months, the company s shares have outperformed the market. This decline comes amidst various developments and new...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.08
Working Capital Ratio 0.87
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -6.8 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash 0.07 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -1,119,849
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.